In patients with COVID-19, preexisting immunity and Omicron infection were associated with reduced disease severity and upper respiratory symptom presentation.

The company announced that the US FDA approved ENFLONSIA™ (clesrovimab-cfor) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates (newborns) and ...

ENFLONSIA is Merck’s extended half-life monoclonal antibody (mAb) indicated for passive immunization for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in ...

Sotatercept-csrk was first approved in 2024 to treat pulmonary arterial hypertension (PAH) in adults based on results seen in the phase 3 STELLAR trial.

A meta-analysis shows moderate evidence that respiratory muscle training improves lung function, particularly respiratory muscle strength, in patients with amyotrophic lateral sclerosis.

Chronic obstructive pulmonary disease (COPD) affects more than 400 million people, continues to be the third cause of death ...

NOPD investigates shooting on Deslonde Street; victim taken to hospital for treatment.

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.

The expert panel will discuss the importance of managing upper and lower inflammatory airway diseases together and how the evolving treatment landscape may affect clinical practice.

Objective To determine the incidence of acute respiratory illness (ARill) in athletes and by method of diagnosis, anatomical classification, ages, levels of performance and seasons. Design Systematic ...